Advertisement
Home Tags Eye / Vision Problems: Misc.

Tag: Eye / Vision Problems: Misc.

April 2015 Briefing – Ophthalmology

Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for April 2015. This roundup includes the latest...
Intensive management of type 1 diabetes can reduce the risk of having a diabetes-related ocular surgery by nearly 50 percent

Intensive T1DM Control Greatly Lowers Odds of Ocular Surgery

Even modest period of tight control can lower need for eye surgery
There is considerable worldwide variation in antibiotic prescribing practices following eyelid surgery

Global Variation in Antibiotic Rx Practices After Eyelid Sx

Greatest predictor of antibiotic prescribing practices is geographic location
Phenytoin appears to be neuroprotective in acute optic neuritis

AAN: Phenytoin Neuroprotective in Optic Neuritis

Adjusted eye retinal nerve fiber layer thickness higher for those receiving phenytoin versus placebo
Adverse ocular effects from aesthetic facial procedures are infrequent

Adverse Ocular Effects From Aesthetic Facial Tx Rare

Cosmetic procedure professionals should be aware of the risks, authors say
Periocular basal cell carcinomas have a mean growth rate of 11.2 mm² every 30 days

Periocular Basal Cell Carcinomas Can Grow Rapidly

Faster growth rate seen in association with recurrent tumors, larger tumors at presentation, male sex
After pterygium excision

Healing Indicators After Pterygium Excision Proposed

Based on OCT imaging, tissue restoration seems to start in cornea and end in the limbal area

March 2015 Briefing – Ophthalmology

Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for March 2015. This roundup includes the latest...
Community optometrists have moderate inter-observer agreement for grading limbal anterior chamber depth

Equivalent Glaucoma Grading Seen by Specialty Optometrists

Moderate agreement for community optometrists grading limbal anterior chamber depth
U.S. Food and Drug Administration approval of Eylea (aflibercept) has been expanded to treat diabetic retinopathy among people with diabetic macular edema

FDA: Eylea Approval Expanded to Include Diabetic Retinopathy

Among people with diabetic macular edema